pravastatin has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gussekloo, J; Jukema, JW; le Cessie, S; Marijt, KA; Mooijaart, SP; Rostamian, S; Trompet, S; van Buchem, MA; van Hall, T | 1 |
| de Craen, AJ; Ford, I; Jukema, JW; Mooijaart, SP; Muller, M; Sabayan, B; Sattar, N; Stott, DJ; Trompet, S; Welsh, P; Westendorp, RG; Wijsman, LW | 1 |
1 review(s) available for pravastatin and Cognitive Decline
| Article | Year |
|---|---|
Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cognition; Cognitive Dysfunction; Female; Humans; Male; Neoplasms; Pravastatin; Prospective Studies | 2022 |
1 trial(s) available for pravastatin and Cognitive Decline
| Article | Year |
|---|---|
High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Cognition; Cognitive Dysfunction; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Prognosis; Prospective Studies; Risk Factors; Troponin T | 2016 |